Charlene McDanal

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott et al. · Science · 2022 · 1.2K citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +9

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

Carl Wild, D C Shugars, Teresa Greenwell et al. · Proceedings of the National Academy of Sciences · 1994 · 932 citations · Full text

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

J R Rusche, Kashi Javaherian, Charlene McDanal et al. · Proceedings of the National Academy of Sciences · 1988 · 623 citations · Full text

Viral Envelope, Human Retrovirus, Immunology +13

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

Kashi Javaherian, A J Langlois, Charlene McDanal et al. · Proceedings of the National Academy of Sciences · 1989 · 618 citations · Full text

Viral Replication, Immunology, Molecular Biology +19

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Carl Wild, Terrence G. Oas, Charlene McDanal et al. · Proceedings of the National Academy of Sciences · 1992 · 486 citations · Full text

Immunology, Molecular Biology, Synthetic Peptide Inhibitor +23